Welcome to Sanofi in the United Kingdom We aim to protect, enable and support people as a health journey partner Our structure With more than 100,000 people across 100 countries, we transform scientific innovation into healthcare solutions to support people across the country, and the globe. We are made up of four Global Business Units (GBUs): Specialty Care (Sanofi Genzyme), Vaccines (Sanofi Pasteur), General Medicines and Consumer Healthcare, and have a strong heritage and presence in the UK. Sanofi Genzyme Providing hope to people with high unmet needs including atopic dermatitis, rheumatoid arthritis, multiple sclerosis and ultra-rare diseases. With specialty care and treatments for patient populations of under 200 to in excess of 100,000. Sanofi Pasteur Preventing infectious diseases at all stages of life through vaccination. With a portfolio of vaccines offering protection for children and adults, including influenza and travel vaccines. General Medicines Improving the management and quality of life of people living with long-term and chronic conditions. With support programmes and treatments for type 1 and 2 diabetes, cardiovascular disease and a portfolio of well-established medicines for the treatment of conditions including venous thrombosis, epilepsy and mental health. Consumer Healthcare Serving healthier, fuller lives through the self-care of common minor ailments. With over the counter medicines for pain care, allergies, nutritional health and digestive health. With our head office in Reading, manufacturing in Haverhill, and our R&D site in Cambridge over 1,100 employees deliver our healthcare solutions across the country. Reading UK Head Office 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT +44 (0) 1183 543 000 Fax: +44 (0) 800 471 8627 DIRECTIONS Haverhill Manufacturing 12 Rookwood Way Haverhill Suffolk CB9 8PU +44 (0) 1440 703 522 Fax: +44 (0) 1440 716 269 DIRECTIONS Cambridge R&D The Bennet Building (B930) Babraham Research Campus Cambridge CB22 3AT +44 (0) 1223 833 301 Fax: +44 (0) 1223 839 133 DIRECTIONS MAT-GB-2003161(v2.0) Date of Preparation July 2021 Follow us Sanofi UK on Twitter Sitemap Terms of Use Privacy Policy Cookie Policy Other Legal Notices Modern Slavery Act Statement © 2018-2021 Sanofi - All rights reserved MAT-GB-2001217(v2.0) - February 2021 Your privacy is important to us By clicking “Accept All ”, you agree to the storing of cookies on your device to enhance site navigation and measure site performance. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third-parties intervening on our website, please consult the “Cookies Policy” available in the site footer. Cookies settings Reject all Accept all